Dexlansoprazole
Dexilant, Dexilant Solutab (dexlansoprazole) is a small molecule pharmaceutical. Dexlansoprazole was first approved as Dexilant on 2009-01-30. It is used to treat gastroesophageal reflux, heartburn, and peptic esophagitis in the USA. Dexilant's patents are valid until 2032-03-05 (FDA).
| Trade Name | Dexilant, Dexilant Solutab |
|---|---|
| Common Name | Dexlansoprazole |
| Indication | gastroesophageal reflux, heartburn, peptic esophagitis |
| Drug Class | Antiulcer agents (benzimidazole derivatives) |
